A variety of new triazole and Aza-β-lactam derivatives derived from o-(N-propargyl) sulfonamido benzoic acid (1a) were synthesized. Firstly, reaction of compound (1a) with absolute ethanol, in the presence concentrated H2SO4 gave ethyl-o-(N-propargyl)sulfoamido benzoate (2a). Subsequently, the produced react with 80% hydrazine hydrate gave o-(N-propargyl)sulfonamido benzohydrazide (3a). The cyclization of (3a) with carbon disulfide and hydrazine hydrate (80%) in presence potassium hydroxide gave o-(4-amino-5-mercapto-1,2,4-triazol-3-yl)-N-propargyl benzene sulfonamide compound (4a). N-propargyl-o-[N\-sulfamidobenzoyl] hydrazine carboxamide (5a) was obtained by reaction of (3a) with Phenyl isocyanates. The cyclization of compound (5a) with 30% NaOH gave 3-hydroxy-4-phenyl-1,2,4-triazole compound (6a). The Schiff bases (7a-b) were obtained by condensation of (3a) with 4-(N,N-dimethyl amino)benzaldehyde and p-nitrobenzaldehyde. Aza-β-lactam compounds (8a-b) were prepared by the cycloaddition of Schiff-bases (7a-b) with phenyl isocyanate via [2+2] cycloaddition reaction. The newly prepared compounds were identified by (FTIR), (1H-NMR) and their physical properties were measured. The compounds were tested for their biological activity, some compound was active and others were not.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report